Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jan-Jun;38(1):1-9.
doi: 10.4103/ijstd.IJSTD_26_17.

Pre- and post-sexual exposure prophylaxis of HIV: An update

Yogesh S Marfatia  1 , Sheethal K Jose  1 , Reema R Baxi  1 , Ruchi J Shah  1
Affiliations
Review

Pre- and post-sexual exposure prophylaxis of HIV: An update

Yogesh S Marfatia et al. Indian J Sex Transm Dis AIDS. 2017 Jan-Jun.

Abstract

Pitfalls in current HIV prevention strategies include late HIV testing, vulnerability among youth and females; lack of emphasis on treatment, low acceptance of circumcision, and nonavailability of protective vaccines. Continuing high-risk sexual behavior, forceful sex, coercive and nonconsensual sex, rape, and unprotected sexual activities make women the most vulnerable to acquisition of sexually transmitted infection/HIV and necessitates a more radical approach of prevention in high-risk individuals who do not have HIV. Preexposure prophylaxis is defined as the administration of antiretroviral drugs to an uninfected person before potential HIV exposure to reduce the risk of infection and continued during risk. The rationale of this approach is to administer preventive dose of drug(s) before exposure to HIV so the moment virus enters the body, HIV replication is inhibited and HIV is not able to establish permanent infection. Postexposure prophylaxis (PEP) following potential sexual exposure is an important form of nonoccupational PEP which is an emergency intervention to abort HIV acquisition arising from exposure to HIV-infected blood or potentially infectious bodily fluids following sexual exposure.

Keywords: Emtricitabine; HIV; postexposure prophylaxis following potential sexual exposure; preexposure prophylaxis; tenofovir.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Similar articles

See all similar articles

Cited by

References

    1. Benn P, Fisher M, Kulasegaram R. BASHH; PEPSE Guidelines Writing Group Clinical Effectiveness Group. UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure (2011) Int J STD AIDS. 2011;22:695–708. - PubMed
    1. Training modules for medical officers on HIV Care and treatment (Including ART) NACO: Ministry of Health and Family Welfare; 2007. pp. 159–75.
    1. Naswa S, Marfatia YS. Pre-exposure prophylaxis of HIV. Indian J Sex Transm Dis. 2011;32:1–8. - PMC - PubMed
    1. US Public Health Service. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States – 2014 Clinical Practice Guideline. [Last cited on 2014 Oct 05]. Available from: http://www.cdc.gov/hiv/pdf/PrEPguidelines2014.pdf .
    1. The Hindu: Pre- Exposure Prophylaxis in Gay Men. 2015. Sep 13, [Last accessed on 2017 Jan 10]. Available from: http://www.thehindu.com/sci-tech/health/preexposure-prophylaxis-prevents... .